Navigation Links
Unique DNA Polymerase Formulation Excels in a Broad Range of PCR,,,Applications

m Taq DNA polymerase High Fidelity (Life Technologies, Inc.), a blend developed specifically for high-fidelity PCR applications, and the Expand 20 kbPlus PCR system (Roche Molecular Biochemicals), the only commercial blend specifically formulated for amplifications of extra-long (>20 kb) genomic targets. The range of amplicon lengths synthesized by each formulation was evaluated by amplifying a panel of short genomic DNA targets, ranging in length from 0.1 kb to 0.5 kb (Figure 1) and a panel of extra-long targets, ranging in length from 17 kb to 48 kb (Figure 2). Amplifications were performed under identical conditions (Methods) with the following exceptions: as per the manufacturers recommendations, PCRs were carried out using 2.5 U of Platinum Taq DNA polymerase High Fidelity, 2.6 U of Expand 20 kbPlus PCR system blend, and 2.5 U (<1 kb) or 5 U (>17 kb) of Herculase enhanced DNA polymerase. The 30-kb and 48-kb targets were amplified with the Herculase formulation in the presence of 3% and 7% DMSO, respectively.

Fig.2

The Platinum Taq DNA polymerase High Fidelity exhibited limited target-length capability compared to Herculase enhanced DNA polymerase, which successfully amplified all targets up to 48 kb in length (Figure 1 and Figure 2). Even in amplifications of short targets, the Herculase formulation produced higher product yields than the Platinum Taq blend (Figure 1). Although the Expand 20 kbPlus PCR system successfully amplified the longer 17-kb and 30-kb genomic targets, product yields were highest with the Herculase formulation. Moreover, amplification of the longest 4
'"/>

Source:


Page: All 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Efficiently Insert Unique Restriction Sites into Plasmid Vectors
2. Unique Enhanced DNA Polymerase Delivers High Fidelity and Great PCR Performance
3. A Unique Dimension in Biological Purity
4. Unique Histochemical Substrate Permits Dual Staining In Animal Tissue
5. Unique Surface Treatment of Novel TSK-GEL ODS Columns Provide Separation of Aqueous and Fat Soluble Vitamins
6. Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase
7. Pfu DNA Polymerase as a Hot Start Alternative
8. PCR Performance Comparisons Between pfuturbo and Taq DNA Polymerases
9. pfuturbo DNA Polymerase: A High-Performance, High-Fidelity Enzyme Ideal for PCR Cloning
10. Enhanced Amplification of Long Targets with PfuTurbo DNA Polymerase
11. High-Fidelity PCR with a Novel Polymerase Mixture

Post Your Comments:
(Date:11/5/2009)..., CA, November 5, 2009 S...n using proprietary taste receptor-based technolog...ood, beverage, and ingredient supply industries, t...ncial results for the third quarter ended Septembe...ird quarter of 2009, compared to $4.0 million for ...
(Date:11/5/2009)...exas, Nov. 5 SpineSmith Partners h... to co-develop a unique scaffold that mimics the s...aluation of several commercial products by SpineSm...pany believes the GenOsteo scaffold represents a s...a unique and ideal environment for the delivery of...
(Date:11/5/2009)... Drug safety specialty firm BioSoteria a...Informatics earned the Certified Professional in L...rom the American Society for Training and Developm...ell has more than fifteen years of medical communi... responsible for the development of the company,s ...
(Date:11/5/2009)... Brooke Sanders brings a new look to Pro...B) November 5, 2009 -- Professional Reprographics,...cs company is pleased to present Brooke Sanders to...aphics/PR specialist. The addition of Brooke to th...th within Professional Reprographics., , ,Brooke b...
Breaking Biology Technology:SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 2BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 3BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 4
...ay 29 The Gerresheimer,Group today opened a new p...The high-tech production facility constructed in D...ers. Specializing in high-quality pharmaceutical,v...s the pharma & life,science industry on both a...EO of Gerresheimer AG, describes the investment as...
...RNewswire-FirstCall/ - YM BioSciences Inc. (NYSE A... that identifies, develops and commercializes diff...announced that a poster presentation will report r... BIOMAb/TheraCIM/h-R3) in patients with head and n... India), a licensee of CIMAB SA, YM,s licensor, at...
...0th patient was supported with the,Berlin Heart EX...nown as the,"Berlin Heart") since the first implan...onth-old girl, received the device at the Children...ssfully transplanted in the meantime. , Alejan...h left,ventricular non compaction and dilative car...
Other Biology Technology:Gerresheimer Opens New High-Tech Production Facility for Pharma Glass in China 2Gerresheimer Opens New High-Tech Production Facility for Pharma Glass in China 3YM BIOSCIENCES ANNOUNCES RESULTS OF RANDOMIZED NIMOTUZUMAB STUDY TO BE PRESENTED IN A POSTER AT ASCO ANNUAL MEETING 2YM BIOSCIENCES ANNOUNCES RESULTS OF RANDOMIZED NIMOTUZUMAB STUDY TO BE PRESENTED IN A POSTER AT ASCO ANNUAL MEETING 3500th Patient Receives Berlin Heart EXCOR Pediatric Ventricular Assist Device 2
(Date:11/5/2009)...The National Association of Biology Teachers (NABT...f biological sciences at Naugatuck Valley Communit...he 2009 Evolution Education Award during the NABT ...eld 11-14 November 2009 in Denver, Colorado. , T... American Institute of Biological Sciences,(AIBS)...
(Date:11/4/2009)... LEADS: (top news in natural science) , Unit...tates uses less water today than it did 35 years a...ines in water use are partly attributable to alter...ficient irrigation systems. According to the lates...used in the United States goes to cooling thermoel...
(Date:11/4/2009)...The Singapore laboratory that deciphered the DNA c...) and elephant shark, has joined The Genome 10K Pr...ble repository of DNA sequences on 10,000 species ... scale that currently can not be achieved. , Par... a paper published in the Nov. 5, 2009 issue of th...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7Singapore scientists join international study of 10,000 vertebrates' genomes 2American Pacific to Release Financial Results and Hold Fiscal 2009 Third Quarter Investor Teleconference 53006 1American Pacific to Release Financial Results and Hold Fiscal 2009 Third Quarter Investor Teleconference 53006 2Thousands of Maine Residents Could Lose Private Insurance Study Shows 53001 1Thousands of Maine Residents Could Lose Private Insurance Study Shows 53001 2Cell Therapeutics Inc Announces Closing of Public Offering of Common Stock and Warrants 52996 1Cell Therapeutics Inc Announces Closing of Public Offering of Common Stock and Warrants 52996 2
...g to the growing popularity of a plant-based sweet...y announced it is developing a new standard to be ...ll help food and beverage manufacturers assure the...omments from the food and beverage industry as wel...new standard for this new sweetener, Rebaudioside ...
...g? , A new study suggests that while health care ...conomy, achieving a substantial, sustainable reduc...he author, who completed health care policy litera...spite far greater expenditures, US hospitalization...ds are all lower than they are in other first-worl...
...atments is the difficulty of aiming these treatmen...ealthy cells in the process. But a new study by Mc... into how scientists might develop therapies and d...ing normal healthy cells , Mick Bhatia, scientifi...search Institute in the Michael G. DeGroote School...
Other Biology News:New standard for popular stevia-based sweetener to assure product's quality 2Plastic and reconstructive surgery -- in brief 2Plastic and reconstructive surgery -- in brief 3Scientists can now differentiate between healthy cells and cancer cells 2
... offers 144 highly successful analytical technique...nd tested protocol contains detailed, step-by-step...ernative procedures, informative explanations and ...ics covered range from protein and peptide electro...
... homogeneous and gradient polyacrylamide gels.Sepa...and isoelectric focusing gels.Save time and improv..., and staining kits.Achieve detection sensitivity ...use silver staining kits. Category: Electrophoresi...
Pig Serum Non-Sterile Trace-Hemolyzed from Pel-Freez Biologicals
Rhesus Serum from Innovative Research
Biology Products: